Attendo AB (publ) (ATT.ST)
SEK 51.8
(1.77%)
SEK 51.8
(1.77%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.29 Billion SEK | -14.7% |
| 2022 | 1.51 Billion SEK | 6.75% |
| 2021 | 1.42 Billion SEK | 9.16% |
| 2020 | 1.3 Billion SEK | 129.11% |
| 2019 | 567.8 Million SEK | -33.13% |
| 2018 | 849.1 Million SEK | -71.24% |
| 2017 | 2.95 Billion SEK | 229.16% |
| 2016 | 896.8 Million SEK | 5.52% |
| 2015 | 849.9 Million SEK | -80.12% |
| 2014 | 4.27 Billion SEK | -47.28% |
| 2013 | 8.1 Billion SEK | 7.56% |
| 2012 | 7.53 Billion SEK | 8.44% |
| 2011 | 6.95 Billion SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 261 Million SEK | -3.69% |
| 2024 Q3 | 502 Million SEK | 92.34% |
| 2024 Q1 | 271 Million SEK | 2.26% |
| 2023 Q2 | 255 Million SEK | 18.6% |
| 2023 Q1 | 215 Million SEK | 110.78% |
| 2023 Q3 | 513 Million SEK | 101.18% |
| 2023 FY | 1.29 Billion SEK | -14.7% |
| 2023 Q4 | 265 Million SEK | -48.34% |
| 2022 FY | 1.51 Billion SEK | 6.75% |
| 2022 Q4 | 102 Million SEK | -58.7% |
| 2022 Q3 | 247 Million SEK | 197.59% |
| 2022 Q2 | 83 Million SEK | -32.52% |
| 2022 Q1 | 123 Million SEK | -20.13% |
| 2021 Q1 | 98 Million SEK | -89.24% |
| 2021 Q2 | 127 Million SEK | 29.59% |
| 2021 Q3 | 302 Million SEK | 137.8% |
| 2021 Q4 | 154 Million SEK | -49.01% |
| 2021 FY | 1.42 Billion SEK | 9.16% |
| 2020 Q3 | 1.04 Billion SEK | 9.68% |
| 2020 Q4 | 911 Million SEK | -12.57% |
| 2020 FY | 1.3 Billion SEK | 129.11% |
| 2020 Q1 | 998 Million SEK | 8.24% |
| 2020 Q2 | 950 Million SEK | -4.81% |
| 2019 Q1 | 954 Million SEK | 0.42% |
| 2019 Q2 | 876 Million SEK | -8.18% |
| 2019 Q3 | 1.04 Billion SEK | 19.29% |
| 2019 FY | 567.8 Million SEK | -33.13% |
| 2019 Q4 | 922 Million SEK | -11.77% |
| 2018 FY | 849.1 Million SEK | -71.24% |
| 2018 Q4 | 950 Million SEK | -6.95% |
| 2018 Q3 | 1.02 Billion SEK | 17.09% |
| 2018 Q2 | 872 Million SEK | -39.4% |
| 2018 Q1 | 1.43 Billion SEK | 7.47% |
| 2017 Q2 | 1.23 Billion SEK | -0.88% |
| 2017 FY | 2.95 Billion SEK | 229.16% |
| 2017 Q3 | 1.29 Billion SEK | 5.27% |
| 2017 Q4 | 1.33 Billion SEK | 3.16% |
| 2017 Q1 | 1.24 Billion SEK | 31.78% |
| 2016 Q1 | 841 Million SEK | -6.66% |
| 2016 FY | 896.8 Million SEK | 5.52% |
| 2016 Q3 | 995 Million SEK | 11.05% |
| 2016 Q2 | 896 Million SEK | 6.54% |
| 2016 Q4 | 944 Million SEK | -5.13% |
| 2015 FY | 849.9 Million SEK | -80.12% |
| 2015 Q4 | 901 Million SEK | 2.62% |
| 2015 Q1 | 752 Million SEK | 3.16% |
| 2015 Q2 | 745 Million SEK | -0.93% |
| 2015 Q3 | 878 Million SEK | 17.85% |
| 2014 Q3 | 795 Million SEK | 0.0% |
| 2014 FY | 4.27 Billion SEK | -47.28% |
| 2014 Q4 | 729 Million SEK | -8.3% |
| 2013 FY | 8.1 Billion SEK | 7.56% |
| 2012 FY | 7.53 Billion SEK | 8.44% |
| 2011 FY | 6.95 Billion SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ambea AB (publ) | 2.14 Billion SEK | 39.692% |
| Humana AB (publ) | 757 Million SEK | -70.806% |
| ProstaLund AB (publ) | 15.65 Million SEK | -8160.925% |